FindTrial
Sign In

Efficacy and Tolerability of Ketomousse, Ketoconazole 1 , Salicilic Acid and Zinc phyritione thermolabile foam in the treatment of Pityriasis Versicolor in comparison with Ketoconazole 2 cream Nizoral

Efficacy and Tolerability of Ketomousse, Ketoconazole 1 , Salicilic Acid and Zinc phyritione thermolabile foam in the treatment of Pityriasis Versicolor in comparison with Ketoconazole 2 cream Nizoral

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-000785-39-IT
Enrollment
60
Registered
2006-01-03
Start date
2005-09-21
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PITYRIASIS VERSICOLOR MedDRA version: 6.1 Level: PT Classification code 10056131

Interventions

Product Name: KETOMOUSSE Pharmaceutical Form: Cutaneous foam Concentration unit: g gram(s) Concentration type: equal Concentration number: 3- Concentration unit: g gram(s) Concentration type: equal Co

Sponsors

MIPHARM
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026